Journal article · 2026
The unfulfilled promise of effective cancer medicines priced beyond reach
The Lancet Oncology, 27(11), 1347–1349 · Published 26 October 2026 · DOI 10.1016/s1470-2045(26)00533-4
In brief
“The unfulfilled promise of effective cancer medicines priced beyond reach” is a 2026 journal article by Christopher M. Booth and 11 co-authors, published in The Lancet Oncology. OpenAlex counts 0 citations as of 17 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 0
- References
- 7
- Authors
- 12
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Booth, C. M., Taylor, C. W., Jackson, C. G. C. A., Tregear, M., Sengar, M., Wilson, B. E., Tannock, I. F., Gyawali, B., Berry, S. R., Verduzco-Aguirre, H. C., Leroux, C., & Sullivan, R. (2026). The unfulfilled promise of effective cancer medicines priced beyond reach. The Lancet Oncology, 27(11), 1347–1349. https://doi.org/10.1016/s1470-2045(26)00533-4
MLA 9
Booth, Christopher M., et al. “The unfulfilled promise of effective cancer medicines priced beyond reach.” The Lancet Oncology, vol. 27, no. 11, 2026, pp. 1347–1349. https://doi.org/10.1016/s1470-2045(26)00533-4.
Chicago
Booth, Christopher M., Carolyn W. Taylor, Christopher G C A Jackson, Michelle Tregear, Manju Sengar, Brooke E. Wilson, Ian F. Tannock, et al. 2026. “The unfulfilled promise of effective cancer medicines priced beyond reach.” The Lancet Oncology 27 (11): 1347–1349. https://doi.org/10.1016/s1470-2045(26)00533-4.
Harvard
Booth, C. M. et al. (2026) ‘The unfulfilled promise of effective cancer medicines priced beyond reach’, The Lancet Oncology, 27(11), pp. 1347–1349. doi:10.1016/s1470-2045(26)00533-4.
IEEE
C. M. Booth et al., “The unfulfilled promise of effective cancer medicines priced beyond reach,” The Lancet Oncology, vol. 27, no. 11, pp. 1347–1349, 2026, doi: 10.1016/s1470-2045(26)00533-4.
BibTeX
@article{booth2026unfulfilled,
title = {{The unfulfilled promise of effective cancer medicines priced beyond reach}},
author = {Booth, Christopher M. and Taylor, Carolyn W. and Jackson, Christopher G C A and Tregear, Michelle and Sengar, Manju and Wilson, Brooke E. and Tannock, Ian F. and Gyawali, Bishal and Berry, Scott R. and Verduzco-Aguirre, Haydeé Cristina and Leroux, Craig and Sullivan, Richard},
journal = {The Lancet Oncology},
year = {2026},
volume = {27},
number = {11},
pages = {1347--1349},
doi = {10.1016/s1470-2045(26)00533-4},
url = {https://doi.org/10.1016/s1470-2045(26)00533-4}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- cancer drug pricing
- daraxonrasib
- RAS inhibitors
- pancreatic cancer
- drug affordability
- anticancer drug development
- unmet medical needs
Work with this paper
Most-cited papers in Economics, Econometrics and Finance
- Theory of the firm: Managerial behavior, agency costs and ownership structureMichael C. Jensen, William H. Meckling · Journal of Financial Economics · 1976 · 77,585 citations
- Institutions, Institutional Change and Economic PerformanceDouglass C. North · Cambridge University Press eBooks · 1990 · 34,377 citations
- The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.John E. Ware, Cathy Donald Sherbourne · PubMed · 1992 · 33,943 citations
- Some Tests of Specification for Panel Data: Monte Carlo Evidence and an Application to Employment EquationsManuel Arellano, Stephen R. Bond · The Review of Economic Studies · 1991 · 33,778 citations
- Co-Integration and Error Correction: Representation, Estimation, and TestingRobert F. Engle, C.W.J. Granger · Econometrica · 1987 · 32,847 citations
Questions about this paper
How do I cite this paper in APA style?
Booth, C. M., Taylor, C. W., Jackson, C. G. C. A., Tregear, M., Sengar, M., Wilson, B. E., Tannock, I. F., Gyawali, B., Berry, S. R., Verduzco-Aguirre, H. C., Leroux, C., & Sullivan, R. (2026). The unfulfilled promise of effective cancer medicines priced beyond reach. The Lancet Oncology, 27(11), 1347–1349. https://doi.org/10.1016/s1470-2045(26)00533-4
How many times has this paper been cited?
0 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Christopher M. Booth, Carolyn W. Taylor, Christopher G C A Jackson, Michelle Tregear, Manju Sengar, Brooke E. Wilson, Ian F. Tannock, Bishal Gyawali, Scott R. Berry, Haydeé Cristina Verduzco-Aguirre, Craig Leroux, Richard Sullivan.
What is the DOI of this paper?
10.1016/s1470-2045(26)00533-4, permanently at https://doi.org/10.1016/s1470-2045(26)00533-4. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.